Roche has reached an agreement to acquire Flatiron Health, a NYC-based oncology EHR startup focused on accelerating cancer research and improving patient care for $1.9B. Under terms of the acquisition, Flatiron Health will continue its current business model, network of partnerships and overall objectives. The integrity of segregated patient protected health information will be preserved, as will dedicated sales and marketing, provider-facing and life science business activities. In addition,
Read More
Precision Oncology
TriNetX Develops Algorithm for Deducing The Chemotherapy Line of Treatment
TriNetX, the global health research network representing nearly 100 million patients, has developed a groundbreaking chemotherapy lines of treatment identification algorithm that understands treatment patterns to deduce the line of chemotherapy treatment a patient is undergoing. This information, up to now nearly impossible to obtain, is critical for biopharmaceutical companies striving to develop therapies for patients involved in care regimens beyond first line treatments.Chemotherapy lines
Read More
Syapse Lands $30M to Expand Precision Oncology to More Healthcare Providers
Syapse, a a San Francisco, CA-based provider of precision oncology solutions, has raised $30 million in Series D financing. Participants include existing investors Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Safeguard Scientifics, and Social Capital, as well as new investors Amgen Ventures, Medidata Solutions, Merck Global Health Innovation Fund, and Roche Venture Fund.The company plans to use the latest round of funding to expand operations and bring its precision
Read More
